Clinical Trial Management System Capability Analysis
Jump to navigation
Jump to search
A Clinical Trial Management System Capability Analysis is a System Capability Analysis for a CTMS.
References
2018
- (Fogel, 2018) ⇒ David B. Fogel. (2018). “Factors Associated with Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review.” In: Contemporary Clinical Trials Communications, 11.
Factor | Opportunity | Role for Artificial Intelligence |
---|---|---|
Poor study design | More complete literature review | |
Appropriate endpoints | ||
Inappropriate eligibility criteria | ||
Appropriate statistical analysis | ||
Determination of appropriate sample size | ||
Reducing likelihood of amendments | ||
Inconsistencies in protocol | ||
Ineffective site selection | ||
Poor recruitment | Improved use of funds | |
Ensuring appropriate eligibility criteria | ||
Facilitating locating eligible patients | ||
Enrolling patients who are likely to complete the trial | ||
Patient burden/safety | ||
Minimize out-of-pocket expenses | ||
Minimize possibility of contraindicated medicines/procedures | ||
Increase likelihood of feeling respected | ||
Poor trial execution | ||
Preparing data and reporting for write-up | ||
Lack of general awareness | ||
Overall | Factor analysis to improve trade-offs based on budget and other constraints |